|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2020
12 months to Jun 30, 2021
|
FY2019
12 months to Jun 30, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Loss from equity method investments in unconsolidated affiliates | |||||
| Loss (gain) from equity method investments | |||||
| Gain on dilution of equity method investments | |||||
| Loss (gain) on sale of equity method investments | |||||
| Gain on equity securities | |||||
| Deferred taxes | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| Noncash lease expense | |||||
| Loss on sale of assets | |||||
| Unrealized loss on investment | |||||
| Noncash impairment charges | |||||
| Unrealized foreign currency translation (gains) losses | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Other assets | |||||
| Operating lease liabilities | |||||
| Accounts payable | |||||
| Accrued provisional revenue adjustment | |||||
| Payables to affiliates | |||||
| Other liabilities and accrued expenses | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Advances to affiliates | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from sale of shares in equity method investments | |||||
| Additions to equity method investments | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuances of common stock, net of issuance costs | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from Credit Facility | |||||
| Settlements of Credit Facility | |||||
| Payments of debt obligations and insurance premiums financed | |||||
| Payments to tax authorities for employee stock-based compensation | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash and cash equivalents at beginning of period | |||||
| Effect of exchange rate changes on cash | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Noncash capital expenditures in accounts payable and accrued expenses | |||||
| Cash paid for interest | |||||
| Capitalized stock-based compensation | |||||
| Noncash acquisitions of mining interests financed by sellers | |||||
| Noncash investment in affiliates for issuance of company stock | |||||
Loading...